Wellington Management Group LLP Blueprint Medicines Corp Transaction History
Wellington Management Group LLP
- $503 Billion
- Q1 2025
A detailed history of Wellington Management Group LLP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Wellington Management Group LLP holds 3,073,306 shares of BPMC stock, worth $394 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
3,073,306Holding current value
$394 Million% of portfolio
0.05%Shares
22 transactions
Others Institutions Holding BPMC
# of Institutions
391Shares Held
68.5MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$852 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$851 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$694 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$493 Million5.51% of portfolio
-
State Street Corp Boston, MA2.68MShares$344 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.65B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...